You are currently viewing a new version of our website. To view the old version click .

Hematology Reports, Volume 17, Issue 5

October 2025 - 13 articles

Cover Story: Once considered incidental immature B-cell precursors, hematogones are now recognized as significant biomarkers for post-transplant recovery. Recent retrospective analysis demonstrates that patients exhibiting durable hematogone expansion post-allogeneic hematopoietic stem cell transplantation (HSCT) experience superior overall and relapse-free survival, independent of graft source or graft-versus-host disease. These cells function as intrinsic indicators of marrow fitness, reflecting the underlying health of the hematopoietic niche. This offers clinicians a straightforward, cost-effective metric to monitor engraftment and regenerative capacity. Their presence signifies robust immune reconstitution, while their absence may indicate heightened vulnerability, establishing hematogones as critical, albeit silent, narrators of transplant success. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (13)

  • Article
  • Open Access
668 Views
20 Pages

Vitamin K Antagonists (VKAs) and Novel Oral Anticoagulants (NOACs) Safety Comparison Based on Data from EudraVigilance Database

  • Pier Paolo Olimpieri,
  • Fanny Erika Palumbo,
  • Gaetano Giuffrida,
  • Edoardo Milanetti,
  • Cecilia Gozzo,
  • Elisa Lucia Scebba,
  • Giovanni Luca Romano,
  • Giovanni Enrico Lombardo,
  • Andrea Duminuco and
  • Calogero Vetro
  • + 5 authors

Background: Clinical trials comparing novel oral anticoagulants (NOACs) with warfarin reported a lower mortality rate and a reduced incidence of bleeding with NOACs. However, these studies do not allow for final conclusions about safety. Moreover, di...

  • Article
  • Open Access
410 Views
9 Pages

Real-World Assessment of Pharmacokinetics, Clinical Outcomes, and Costs After Switching from Standard Half-Life to Extended Half-Life FVIII in Well-Controlled Hemophilia A Patients

  • Maria Choví-Trull,
  • Juan Eduardo Megías-Vericat,
  • Santiago Bonanad-Boix,
  • Saturnino Haya-Guaita,
  • Ana Rosa Cid-Haro,
  • Marta Aguilar-Rodriguez,
  • Tomás Palanques-Pastor,
  • Javier Garcia-Pellicer and
  • Jose Luis Poveda-Andrés

Objective: This study aimed to analyze pharmacokinetic and clinical parameters (bleeding rates and joint health) before and after switching from standard half-life (SHL) factor VIII (FVIII) to extended half-life (EHL) PEGylated turoctocog alfa pegol...

  • Case Report
  • Open Access
560 Views
7 Pages

Background and Clinical Significance: Acquired hemophilia A (AHA) and acquired von Willebrand syndrome (AVWS) are rare bleeding disorders that do not often present concurrently. Here, we report a coexisting AHA and AVWS case due to underlying autoant...

  • Article
  • Open Access
540 Views
11 Pages

Background: Immune-mediated thrombotic thrombocytopenic purpura (iTTP) survivors exhibit increased rates of psychological comorbidities, cognitive impairment (CI), and reduced health-related quality of life (HRQoL). This cross-sectional study investi...

  • Review
  • Open Access
835 Views
11 Pages

Background: Hemophagocytic lymphohistiocytosis (HLH) is a rare, life-threatening hyperinflammatory syndrome characterized by uncontrolled macrophage activation. Secondary HLH is more common in adults and may be triggered by infection, malignancy, or...

  • Case Report
  • Open Access
876 Views
8 Pages

The Presentation, Diagnosis, and Management of Autosomal Dominant Common Variable Immunodeficiency Type XII with NFKB1 Mutation and Autoimmune Neutropenia Treated with Allogenic Stem Cell Transplantation

  • Matthew Gold,
  • Chandini Kannan,
  • Ashley Schofield,
  • Alane Rogers,
  • Charles J. Weeks,
  • Sruthi Dontu,
  • Joseph Suchomski,
  • Nabil Ghani,
  • Shawn Doss and
  • Jacob Boccucci
  • + 2 authors

Background and Clinical Significance: Common Variable Immunodeficiency (CVID) is a prevalent manifestation of primary immunodeficiency disorder. The current mainstay of treatment is immunoglobulin replacement therapy; however, in patients with severe...

  • Review
  • Open Access
821 Views
12 Pages

Background/Objectives: In haematology, a wide range of blood disorders are hereditary. The thalassaemias are hereditary anaemias characterised by a high burden of disease at the public health level, challenging the resources of many health systems. T...

  • Case Report
  • Open Access
589 Views
8 Pages

Tyrosine Kinase Inhibitor Treatment of a Patient with Chronic Myeloid Leukemia and Congenital Thrombophilia

  • Carol Herrera-Hernández,
  • Adrián Segura-Diaz,
  • Ruth Stuckey,
  • Juan Francisco López-Rodríguez and
  • María Teresa Gómez-Casares

Background and Clinical Significance: Chronic Myeloid Leukemia (CML) management has been revolutionized by tyrosine kinase inhibitors (TKIs), though cardiovascular and thrombotic complications remain a concern, especially in patients with underlying...

  • Feature Paper
  • Article
  • Open Access
631 Views
14 Pages

Prolonged Hematogone Expansion Is Associated with Better Outcomes in Allogeneic Hematopoietic Stem Cell Transplantation Recipients

  • Bianca Serio,
  • Danilo De Novellis,
  • Marisa Gorrese,
  • Angela Bertolini,
  • Paola Manzo,
  • Francesca Picone,
  • Anna Maria Della Corte,
  • Rossella Marcucci,
  • Denise Morini and
  • Michela Rizzo
  • + 10 authors

Background/Objectives: Hematogones, B cell precursors, are considered a clock of bone marrow reconstitution after chemotherapy and hematopoietic stem cell transplantation (HSCT). Methods: In this retrospective observational monocentric study, we inve...

  • Article
  • Open Access
872 Views
11 Pages

Interplay Between Sickle Cell Disease and Thrombosis: A Single Center Experience of Pathophysiology and Potential Risk Factors

  • Rafail Tzanninis,
  • Efthymia Vlachaki,
  • Eleftheria Lefkou,
  • Stavroula Tsiara,
  • Stamatia Theodoridou,
  • Athanasios Vyzantiadis and
  • Miltiadis Matsagkas

Background: Sickle cell disease (SCD) is among the most prevalent inherited hemoglobinopathies and is strongly associated with numerous coagulation abnormalities, hence constituting a severe hypercoagulable state. Methods: We conducted a single-cente...

of 2

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Hematol. Rep. - ISSN 2038-8330